MIB1 and breast carcinoma: Second, as a control, MIB-1 expression, a marker of tumor cell proliferation and determinant of patient survival in prostate cancer22, shows no correlation with experimental measured proliferation in breast cancer cell lines (Spearman ρ = 0.05, P < 0.76).